Global Assessment of Functioning (GAF) ratings: Determinants and role as predictors of one-year treatment outcomes

Journal of Clinical Psychology

Volumn 56, Issue 4, 2000, Pages 449-461

  Moos, Rudolf H ^a   McCoy, Lucie ^b   Moos, Bernice S ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Clinical diagnoses; Global functioning; Psychiatric symptoms; Substance use disorder; Treatment outcomes

Indexed keywords

ADULT; ARTICLE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PREDICTION; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; DIAGNOSIS, DUAL (PSYCHIATRY); EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 0034127875     PISSN: 00219762     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4679(200004)56:4<449::AID-JCLP1>3.0.CO;2-8     Document Type: Article

References (49)

1. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders (3rd ed., revised). Washington, DC: Author.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Beiser, M., Fleming, J.A.E., Fleming, M.B., Lacono, W.G., & Lin, T (1988). Refining the diagnosis of schizophreniform disorder. American Journal of Psychiatry, 145, 695-700.
4. Bodland, O., Kullgren, G., Ekselius, L., Lindstrom, E., & Von Knorring, L. (1994). Axis V-Global Assessment of Functioning Scale: Evaluation of a self-report version. Acta Psychiatrica Scandinavia, 90, 342-347.
5. Brekke, J.S. (1992). An examination of the relationships among three outcome scales in schizophrenia. Journal of Nervous Mental Disease, 180, 162-167.
6. Coffey, M., Jones, S., & Thornicroft, G. (1996). A brief mental health outcome scale: Relationships between scale scores and diagnostic/sociodemographic variables in the long-term mentally ill. Journal of Psychiatric Mental Health Nursing, 3, 89-93.
7. Coulehan, J., Schulberg, H., Block, M., Madonia, M., & Rodriguez, E. (1997). Treating depressed primary care patients improves their physical, mental, and social functioning. Archives of Internal Medicine, 157, 1113-1120.
8. Derogatis, L. (1993). Brief Symptom Inventory: Administration, scoring, and procedures manual (3rd ed.). Minneapolis, MN: National Computer Systems.
9. Dohrenwend, B.S., Dohrenwend, B.P., Link, B., & Levav, I. (1983). Social functioning of psychiatric patients in contrast with community cases in the general population. Archives of General Psychiatry, 40, 1174-1182.
10. Dufton, B.D., & Siddique, C.M. (1992). Measures in the day hospital: I. The Global Assessment of Functioning Scale. International Journal of Partial Hospitalization, 8, 41-49.
11. Endicott, J., Spitzer, R., Fleiss, J., & Cohen, J. (1976). The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766-771.
12. Furukawa, T., Awaji, R., Nakazato, H., & Sumita, Y. (1995). Predictive validity of subtypes of chronic affective disorders derived by cluster analysis. Acta Psychiatrica Scandinavia, 91, 379-385.
13. Goldman, H.H., Skodol, A.E., & Lave, T.R. (1992). Revising Axis V for DSM-IV: A review of measures of social functioning. American Journal of Psychiatry, 149, 1148-1156.
14. Gordon, R.E., & Gordon, K.K. (1987). Relating Axes IV and V of DSM-III to clinical severity of psychiatric disorders. Canadian Journal of Psychiatry, 32, 423-424.
15. Gordon, R.E., Plutzky, M., Gordon, K.K., & Guerra, M. (1988). Using the Axis V Scale to evaluate therapeutic outcome of psychiatric treatment. Canadian Journal of Psychiatry, 33, 194-196.
16. Hall, R.C.W. (1995). Global Assessment of Functioning: A modified scale. Psychosomatics, 36, 267-275.
17. Hawthorne, W.B., Fals-Stewart, W., & Lohr, J.B. (1994). A treatment outcome study of community-based residential care. Hospital Community Psychiatry, 45, 152-155.
18. Howes, J.L., Haworth, H., Reynolds, P., & Kavanaugh, M. (1997). Outcome evaluation of a short-term mental health day treatment program. Canadian Journal of Psychiatry, 42, 502-508.
19. Jones, S.H., Thornicroft, G., Coffey, M., & Dunn, G. (1995). A brief mental health outcome scale: Reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry, 166, 654-659.
20. Kocsis, J.H., Zisook, S., Davidson, J., Shelton, R., Yonkers, K., Hellerstein, D.J., Rosenbaum, J., & Halbreich, U. (1997). Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Psychosocial outcomes. American Journal of Psychiatry, 154, 390-395.
21. Linehan, M.M., Tutek, D.A., Heard, H.L., & Armstrong, H.E. (1994). Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. American Journal of Psychiatry, 151, 1771-1776.
22. Luborsky, L. (1962). Clinicians' judgments of mental health: A proposed scale. Archives of General Psychiatry, 7, 407-417.
23. Mellsop, G., Peace, K., & Fernando, T. (1987). Pre-admission adaptive functioning as a measure of prognosis in psychiatric inpatients. Australian and New Zealand Journal of Psychiatry, 21, 539-544.
24. Meltzer, H.Y., Thompson, P.A., Myung, A.L., & Ranjan, R. (1996). Neuropsychologic deficits in schizophrenia: Relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology, 14, 27S-33S.
25. Mezzich, J.E., Fabrega, H., & Coffman, G.A. (1987). Multiaxial characterization of depressive patients. Journal of Nervous and Mental Disease, 175, 339-346.
26. Moos R., Finney, J., & Cronkite, R. (1990). Alcoholism treatment: Context, process, and outcome. New York: Oxford.
27. Moos, R., & Moos, B. (1994). Life Stressors and Social Resources Inventory: Adult form manual. Odessa, FL: Psychological Assessment Resources, Inc.
28. Mueser, K.T., Becker, D.R., Torrey, W.C., Xie, H., Bond, G.R., Drake, R.E., & Dain, B.J. (1997). Work and nonvocational domains of functioning in persons with severe mental illness: A longitudinal analysis. Journal of Nervous and Mental Disease, 185, 419-426.
29. Ouimette, P.C., Finney, J.W., & Moos, R. (1997). Twelve step and cognitive behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting Clinical Psychology, 65, 220-234.
30. Patterson, D.A, & Lee, M. (1995). Field trial of the Global Assessment of Functioning Scale -Modified. American Journal of Psychiatry, 152, 1386-1388.
31. Phelan, M., Wykes, T., & Goldman, H. (1994). Global function scales. Social Psychiatry and Psychiatric Epidemiology, 29, 205-211.
32. Piersma, H.L., & Boes, J.L. (1995). Agreement between patient self-report and clinician rating: Concurrence between the BSI and the GAF among psychiatric inpatients. Journal of Clinical Psychology, 51, 153-157.
33. Piersma, H.L., & Boes, J.L. (1997). The GAF and psychiatric outcome: A descriptive report. Community Mental Health Journal, 33, 35-40.
34. Rabinowitz, J., Modai, I., & Inbar-Saban, N. (1994). Understanding who improves after psychiatric hospitalization. Acta Psychiatrica Scandinavia, 89, 152-158.
35. Roy-Byrne, P., Dagadakis, C., Unutzer, J., & Ries, R. (1996). Evidence for limited validity of the revised Global Assessment of Functioning Scale. Psychiatric Services, 47, 864-866.
36. Rund, B.R., Sollien, T., Fjell, A., Borchgrevink, T., Hallert, M., & Naess, P.O. (1994). The Psychosis Project: Outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents. Acta Psychiatrica Scandinavia, 89, 211-218.
37. Schrader, G., Gordon, M., & Harcourt, R. (1986). The usefulness of DSM-III Axis IV and Axis V assessments. American Journal of Psychiatry, 143, 904-907.
38. Skodol, A.E., Link, B.C., Shrout, P.E., & Horwath, E. (1988a). The revision of Axis V in DSM-III-R: Should symptoms have been included? American Journal of Psychiatry, 145, 825-829.
39. Skodol, A.E., Link, B.G., Shrout, P.E., & Horwath, E. (1988b). Toward construct validity for DSM-III Axis V. Psychiatry Research, 24, 13-23.
40. Strauss, J.S., & Carpenter, W.T. (1977). Prediction of outcome in schizophrenia. Archives of General Psychiatry, 34, 159-163.
41. Sullivan, C.W., & Grubea, J.M. (1991). Who does well in a day treatment program? Following patients through 6 months of treatment. International Journal of Partial Hospitalization, 7, 101-110.
42. Thompson, J.W., Burns, B.J., Goldman, H.H., & Smith, J. (1992). Initial level of care and clinical status in a managed mental health program. Hospital and Community Psychiatry, 43, 599-603.
43. Tracey, K., Adler, L.A., Rotrosen, J., Edson, R., & Lavori, P. (1997). Interrater reliability issues in multicenter trials, Part 1: Theoretical concepts and operational procedures used in Department of Veterans Affairs cooperative study, #394. Psychopharmacology Bulletin, 33, 53-57.
44. Tucker, L., Bauer, S.F., Wagner, S., Harlam, D., & Sher, I. (1987). Long-term hospital treatment of borderline patients: A descriptive outcome study. American Journal of Psychiatry, 144, 1443-1448.
45. Van Gastel, A., Schotte, C., & Maes, M. (1997). The prediction of suicidal intent in depressed patients. Acta Psychiatrica Scandinavia, 96, 254-259.
46. Vetter, P., & Koller, O. (1996). Clinical and psychosocial variables in different diagnostic groups: Their interrelationships and value as predictors of course and outcome during a 14-year follow-up. Psychopathology, 29, 159-168.
47. Walker, R., Minor-Schork, D., Bloch, R., & Esinhart, J. (1996). High risk factors for rehospitalization within six months. Psychiatry Quarterly, 67, 235&243.
48. Walton, S.A., Berk, M., & Brook, S. (1996). Superiority of lithium over verapamil in mania: A randomized, controlled, single-blind trial. Journal of Clinical Psychiatry, 57, 543-546.
49. Westermeyer, J., & Neider, J. (1988). Social networks and psychopathology among substance abusers. American Journal of Psychiatry, 145, 1265-1269.